Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: J Autoimmun. 2018 Jun 20;93:45–56. doi: 10.1016/j.jaut.2018.06.004

Figure 5. IL-12 Neutralization in Germ-free CD25KO mice Improves Autoimmunity.

Figure 5

A-Single cell suspensions were prepared from conventional and germ-free lacrimal glands (LG), cervical lymph nodes (CLN) or conjunctiva and stained with live/dead dye and CD45, IL-12, CD11c, and MHC II antibodies. Single cells, alive CD45+IL-12+ cells were gated and CD11c and MHC II were plotted.

B–D-Germ-free CD25KO mice, aged four weeks of age, received either anti-IL-12 (α-IL-12) or isotype control (IC) antibody bi-weekly i.p. injections (200ug/injection) for a total of 4 weeks while kept in a germ-free isolator. Mice were used at eight weeks of age (n = six/group).

(A) Flow cytometry analysis showing distribution of CD45+IL-12+ cells based on CD11c and MHC II expression; pie charts of means of four samples. Means and SD are shown below. Nonparametric Mann–Whitney U tests were used to make comparisons between germ-free and conventional mice, * P<0.05, ***P<0.001.

(B) Representative pictures of haematoxylin and eosin (H&E)-stained sections of the lacrimal gland. 20X objective, scale bar = 50 μm. (C) Inflammation scores of lacrimal gland pathology. Bar graphs show means ± SEM of two independent experiments, final n = five animals. Nonparametric Mann–Whitney U tests were used to make comparisons.

(D) Flow cytometric analysis of cervical lymph nodes and lacrimal gland. Bar graphs are means ± SD of two independent experiments, with a final sample size of six per group. Parametric t-tests were used to make comparisons between groups.

LG = lacrimal gland; CLN = cervical lymph nodes; NS = non-significant